Crane Co Q3 FY2026 earnings call

• Record Financial Performance: Crane delivered record margins, earnings, and backlog in Q3 2026, driven by broad-based demand across end markets and exceptional execution.
• Strong Acquisition Integration: Recent acquisitions are significantly exceeding expectations, contributing approximately $0.30 per share to 2026 earnings (up from $0.20 previously). The company expects to achieve its 10% Return on Capital (RYC) hurdle approximately 18 months earlier than anticipated.
• Aerospace Demand Resilience: Demand remains robust across commercial aerospace, defense, and space. Defense investment is strong in missile defense, radar, and advanced power conversion. Commercial aftermarket remains healthy alongside solid Original Equipment (OE) demand.
• Process Flow Technologies Momentum: The portfolio transformation is gaining momentum, with growth in cryogenics (space launch), pharmaceuticals (GOP-1 expansion), wastewater, and power. Chemical markets remain flat but are no longer the primary growth driver.
• Strategic Portfolio Actions: The divestiture of Building Services & Utilities (BS&U) completes the exit from non-residential construction exposure. The pending acquisition of Trillium Pumps strengthens the position in water and wastewater markets.
• Operational Excellence: Adjusted operating margin expanded 130 basis points to a record 22.5% at the consolidated level, demonstrating high operating leverage and productivity gains despite acquisition dilution.

Aerospace and Advanced Technologies: Reported sales of $344 million, a 27% year-over-year increase, with core sales up 9.5%. The segment achieved an adjusted operating margin of 26.3%, expanding 100 basis points year-over-year. Backlog reached a record nearly $1.3 billion, up 9% on a core basis. Process Flow Technologies: Reported sales of $413 million, a 29% year-over-year increase, driven by a 6.2% core sales growth and contributions from recent acquisitions. Adjusted operating margins hit a record 24%, expanding 80 basis points year-over-year. Core orders surged 20% year-over-year.

• Full-Year EPS: Raised adjusted full-year EPS guidance by $0.35 at the midpoint to a range of $7.23–$7.38 per share.
• Aerospace Growth: Maintained expectation for 2026 core growth modestly above the high end of the long-term framework (7–9%), leveraging between 35% and 40%.
• Process Flow Technologies: Improved outlook to low single-digit core growth for the full year, driven by solid second-half performance and continued margin expansion.
• Corporate Expenses: Expected to remain within the previously guided range of $80–$85 million for the full year.
• Tax Rate: Estimated effective tax rate for 2026 remains approximately 23%.

• Chemical Market Dependency Shift: While chemical markets are currently flat, the company has successfully reduced dependency on this sector's recovery for overall growth, mitigating risk from potential prolonged downturns in Europe.
• Acquisition Dilution Timing: The sale of BS&U (flat margin) and acquisition of Trillium (below fleet margin) may cause temporary dilution, though management expects Trillium to offset much of this impact upon closing near the end of Q1 2027.
• Geopolitical/Freight Costs: Exposure to the Middle East is less than 5% of total revenue; while some shipment delays occurred earlier in the year, they have normalized, and higher freight costs have been offset by pricing actions.

Q: Analyst asked about the upside potential for the PSI acquisition, noting it is ahead of schedule.

A: Management confirmed the upside is higher than initially projected. The five-year EBITDA target of $150 million will be reached quicker, with both growth and margins expected to exceed prior forecasts beyond that mark. They view this as a combination of faster execution and higher terminal value.

Q: Analyst inquired about future portfolio actions in Process Flow Technologies (PFT) and how Trillium offsets the dilution from selling BS&U.

A: Management stated there are no further substantial divestitures planned, completing the exit from non-residential construction. Regarding dilution, BS&U generates ~$160M at flat margins, while Trillium ($115M) has below-fleet margins. Since Trillium closes near the end of Q1 2027, it will not provide a full-year benefit immediately, but management expects it to offset a significant portion of the dilution within the year.

Q: Analyst sought details on the chemical market recovery and regional outlook.

A: Europe’s chemical market is expected to remain flat. The U.S. market shows sporadic activity due to natural gas feedstock advantages, while the Middle East is recovering. Management emphasized that PFT is now less dependent on chemical recovery for growth, relying instead on structural shifts toward pharma, power, and cryogenics.

Q: Analyst questioned the source of the exceptional core margin expansion in PFT and AAT.

A: CFO explained that core operating leverage in both segments is in the 35–40% range. In AAT, leverage was in the low 40s, driven by price-cost discipline and productivity. In PFT, core leverage was also north of 40%, supported by sustained investments through the cycle and resilient mix dynamics.

Q: Analyst asked about the process for securing Underlying Contract Awards (UCAs) in missile programs.

A: Management noted they participate in ~15 missile programs with current annual run rates around $35M, expecting 40–50% growth next year. The contracting process involves receiving RFQs for multi-year tranches, submitting updated quotes, aligning with customers, and securing contracts/purchase orders incrementally throughout the year.